Tech Company Financing Transactions
Amalgam Rx Funding Round
On 8/12/2025, Amalgam Rx raised $20 million in investment from Catalio Capital Management.
Transaction Overview
Company Name
Announced On
8/12/2025
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to scale its Medical-Grade AI solutions to further empower patients in their daily lives and providers in their clinical workflows.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
1007 North Orange Street 400
Wilmington, DE 19801
USA
Wilmington, DE 19801
USA
Phone
Undisclosed
Website
Email Address
Overview
At Amalgam, we've never been afraid to be the first. Our leadership team has more than 15 years of experience developing, clearing, and deploying groundbreaking patient support programs and SaMD Digital Therapeutics that transform care delivery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ryan Sysko
Chief Financial Officer
Jennifer Main
Chief Technical Officer
Matti Prasad
Browse more venture capital transactions:
Prev: 8/12/2025: Evertune venture capital transaction
Next: 8/12/2025: Profound venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs